Adeno-associated Virus

Symposium highlights AAV gene therapy best practices for children, CHOP researchers develop novel nanopore platform, and more In the News

CHOP researchers developed a factor VIII variant that led to safe and long-lasting therapeutic results in preclinical models.

An infographic and article look at the science behind gene therapy, challenges faced by the field, and the road ahead.